Table 2.
Control | SR | SRPF | Dunn’s adjusted value of p | Dunn’s q value | |
---|---|---|---|---|---|
Haemoglobin (g/dL) | 14.33 [12.89; 15.42] | 13.27 [12.08; 14.41]* | 13.02 [11.93; 14.27]* | 0.0692; 0.0253 | 0.0100; 0.0070 |
Glycate haemoglobin (mmol/mol) | 5.57 [5.20; 5.80] | 5.77 [5.19; 6.28] | 6.24 [5.65; 8.12]*,† | 0.0003; 0.0338 | 0.0003; 0.0074 |
Lymphocytes (x1000/mm3) | 1.89 [1.54; 2.35] | 2.01 [1.56; 2.47]* | 2.27 [1.78; 2.97]* | 0.3877; 0.0035 | 0.0485; 0.0013 |
Platelets (×103/μL) | 242.35 [197.78; 286.95] | 259.10 [213.04; 303.55] | 264.00 [219.35; 316.08] | n.s. | n.s. |
CRP (mg/dL) | 3.96 [1.40; 6.98] | 5.77 [2.82; 10.45]* | 6.08 [3.70; 10.33]* | 0.0692; 0.0422 | 0.0100; 0.0074 |
D-dimer (mg/L) | 410.02 [257.51; 580.05] | 418.01 [228.75; 733.17] | 463.00 [314.00; 720.00] | n.s. | n.s. |
Comparisons were performed using the Kruskal-Wallis test followed by Dunn’s post-hoc test after adjustment by days to follow-up assessment. Statistical significance was considered when q < 0.052 in the Dunn’s post-hoc test. n.s. non-significant in Kruskall-Wallis test, post-hoc test not performed. * vs. Control; † vs. SR; CRP, C-reactive protein; SR, Self-Reported Symptoms group; SRPF, Self-Reported Symptoms and decreased Pulmonary Function group.